China's Innovent Biologics secures over $300m investment from Sanofi

China's Innovent Biologics secures over $300m investment from Sanofi

Photo by RephiLe on Unsplash

05 August, 2022

Printed by Unregistered user on Fri, 24 Oct 2025 06:43:02 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek-backed Innovent Biologics makes 5% gain in Hong Kong debut

Temasek-backed Chinese biotech firm Innovent raises $421m in HK IPO

Read more from Greater China

Beyond the Buyout: Japanese LPs shaping private markets amid slowdown

Chinese robovan startup Neolix raises $600m for product development